Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
This pricing behavior is consistent with a settlement that, in substance, created a managed duopoly during the 180-day window where both Novartis and Sun captured elevated returns relative to a fully competitive generic market rather than a genuinely competitive LOE event
People taking GLP-1 medications commonly report reduced food cravings, less emotional eating, and a quieting of the constant mental preoccupation with food that researchers call "food noise." Animal studies have also shown that GLP-1 receptor activation reduces the rewarding properties of high-calorie food in the brain findings confirmed in a landmark randomized, placebo-controlled neuroimaging study in humans ( van Bloemendaal et al., Diabetes, 2014 )
The composition of GLP-1 prescribing changed markedly over the period
Yeah, but again, still in the normal range
It starts when they realize they dont have to keep fighting the same battle the same way
